27.01.2021 • News

Univar Sells Distrupol to Private Equity

US-based multinational distributor Univar Solutions has agreed to sell its Distrupol subsidiary to GPD Companies, an affiliate of One Rock Capital Partners. Financial terms of the transaction, which is expected to close in the first half of 2021, were not disclosed.

Headquartered in Chertsey, UK, Distrupol is a leading European distributor of thermoplastic polymers and elastomers, serving more than 1,300 customers across 13 countries. Its product range is certified and approved in industries such as automotive, medical, food and electrical. The company operates warehouses in the UK, Ireland, Sweden, Finland and the Netherlands.

"Our acquisition of Distrupol adds to One Rock’s existing holdings in the plastics industry, increases our scale and continues the execution of our strategy to build a leading group of global distributors," said Tony Lee, managing partner of One Rock.

Formerly known as Nexeo Plastics, GPD was formed as a holding company by One Rock following its acquisition by an affiliate of the New York-based investment group in March 2019. That was the same month that Univar closed its purchase of Nexeo Plastics’ parent, Nexeo Solutions.

Distrupol will join GPD’s group once the transaction closes. However, it will continue to operate as a standalone, independent entity under its current brand, led by the existing management and commercial teams.

Author: Elaine Burridge, Freelance Journalist

Univar Solutions has agreed to sell its Distrupol subsidiary to GPD Companies,...
Univar Solutions has agreed to sell its Distrupol subsidiary to GPD Companies, an affiliate of One Rock Capital Partners. Headquartered in Chertsey, UK, Distrupol is a leading European distributor of thermoplastic polymers and elastomers. The deal is due to close in H1 2021. (c) Distrupol

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read